Latest News for: moon lake

Edit

MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis ...

The Daily Record - Dunn 22 Jun 2026
Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa ....
Edit

MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and ...

The Daily Record - Dunn 11 May 2026
MoonLake conducted a positive final pre-BLA (Biologics License Application) meeting with the U.S. Food and Drug ....
  • 1

Article Search

tools
×
×
×
×